Related Experiment Video
Updated: Aug 5, 2025

08:32
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
349
Targeting epigenetic aberrations of sarcoma in CRISPR era
Miwa Tanaka1,2, Takuro Nakamura2
1Project for Cancer Epigenomics, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Genes, Chromosomes & Cancer
|March 26, 2023
Summary
Epigenetic aberrations are crucial for sarcoma development and progression. This review covers epigenetic changes, mouse models, and epigenome editing technologies for sarcoma research and therapy.
Area of Science:
- Oncology
- Genetics
- Epigenetics
Background:
- Sarcomas are rare cancers with diverse characteristics.
- Genetic alterations are key drivers of sarcomagenesis.
- Epigenetic aberrations cooperate with genetic mutations in sarcoma growth.
Purpose of the Study:
- To review epigenetic aberrations in sarcomas.
- To discuss representative mouse models for studying sarcoma.
- To explore epigenome editing technologies for sarcoma research and therapy.
Main Methods:
- Review of scientific literature on sarcoma epigenetics.
- Analysis of genetic and epigenetic interactions in sarcoma development.
- Examination of CRISPR/dCas9-based epigenome editing systems.
Main Results:
- Genetic alterations and epigenetic aberrations are integral to sarcomagenesis.
- Mouse models have significantly advanced understanding of sarcoma biology and tumor microenvironment.
- Epigenome editing technologies offer new avenues for research and therapeutic strategies.
Conclusions:
- Epigenetic aberrations are critical in sarcoma development.
- Advances in mouse models and epigenome editing enhance sarcoma research.
- Epigenetic therapies hold promise for sarcoma treatment.
Related Concept Videos
CRISPR
52.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Conservative Site-specific Recombination and Phase Variation
6.1K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.1K
CRISPR/Cas9 Genome Editing
91
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
91
Homologous Recombination
50.8K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.8K

